Insider Transactions in Q1 2026 at Madrigal Pharmaceuticals, Inc. (MDGL)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 09
2026
|
Paul A Friedman Director |
SELL
Open market or private sale
|
Direct |
24,800
-0.43%
|
$13,069,600
$527.73 P/Share
|
|
Jan 09
2026
|
Paul A Friedman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,800
+5.27%
|
$372,000
$15.8 P/Share
|
|
Jan 09
2026
|
Rebecca Taub Director |
SELL
Open market or private sale
|
Direct |
18,650
-0.13%
|
$9,847,200
$528.25 P/Share
|
|
Jan 09
2026
|
Rebecca Taub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,650
+1.9%
|
$279,750
$15.8 P/Share
|